Can MIGS options such as canaloplasty work for patients with severe glaucoma? Expert Dr. Shamil Patel (United States) says yes—and in this video, he sets out to prove it.
Previously, MIGS was performed to bridge the treatment gap between medications in early stage disease, and invasive surgical options such as trabeculectomy for severe disease. Following the results of his retrospective study which investigated the clinical outcomes of canaloplasty with Nova Eye’s iTrack™ Advance across the full spectrum of glaucoma, Dr. Patel is challenging the notion that MIGS should only be used in cases of early disease. Instead, he recommends that, based on its comprehensive mechanism of action which aims to truly restore physiological outflow, canaloplasty can offer significant utility in cases of severe disease. See the data. Watch now.
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
